FIERCE-HN: A multicenter, randomized, placebo-controlled, phase 3 study of ficlatuzumab + cetuximab in pts w/ recurrent or metastatic (R/M) HPV-negative head and neck squamous cell carcinoma (HNSCC)
ASTRO Poster Library, Julie Bauman,
408919
Olaparib, a poly (ADP-ribose) polymerase (PARP) Inhibitor, in Combination with Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC): A Single-Arm, Phase 2 Trial
ASTRO Poster Library, Peter Oppelt,
408983
A Pilot Study of HNC Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device While Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Reducing the Impact of Oral Mucositis
ASTRO Poster Library, Catherine Holtzapfel,
408970
XRay Vision: a phase 3 study of xevinapant plus radiotherapy (RT) for high-risk, cisplatin-ineligible patients with resected, locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
ASTRO Poster Library, Robert Ferris,
408913
HyperlynX: a phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in patients with unresected locally advanced squamous cell carcinoma of the head and neck
ASTRO Poster Library, Nabil Saba,
408962
Comparison of induction cisplatin, docetaxel, and 5-fluorouracil to an induction platinum doublet regimen for locally advanced human papillomavirus-associated oropharyngeal cancer
ASTRO Poster Library, Ashwin Ganti,
408910
KontRASt-02: A Phase III Trial Investigating the Efficacy and Safety of the KRASG12C Inhibitor JDQ443 vs Docetaxel in Patients With Previously Treated, Locally Advanced or Metastatic, KRAS G12C-Mutated NSCLC
ASTRO Poster Library, Elena Chan,
401278
Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or After Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study
ASTRO Poster Library, Evan Wolf,
401284